Sanyear Chanita, Chiawtada Buraporn, Butthep Punnee, Svasti Saovaros, Fucharoen Suthat, Masaratana Patarabutr
Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
PeerJ. 2021 Apr 30;9:e11367. doi: 10.7717/peerj.11367. eCollection 2021.
Hepcidin controls iron homeostasis by inducing the degradation of the iron efflux protein, ferroportin (FPN1), and subsequently reducing serum iron levels. Hepcidin expression is influenced by multiple factors, including iron stores, ineffective erythropoiesis, and inflammation. However, the interactions between these factors under thalassemic condition remain unclear. This study aimed to determine the hypoferremic and transcriptional responses of iron homeostasis to acute inflammatory induction by lipopolysaccharide (LPS) in thalassemic ( ) mice with/without parenteral iron loading with iron dextran.
Wild type and mice were intramuscularly injected with 5 mg of iron dextran once daily for two consecutive days. After a 2-week equilibration, acute inflammation was induced by an intraperitoneal injection of a single dose of 1 µg/g body weight of LPS. Control groups for both iron loading and acute inflammation received equal volume(s) of saline solution. Blood and tissue samples were collected at 6 hours after LPS (or saline) injection. Iron parameters and mRNA expression of hepcidin as well as genes involved in iron transport and metabolism in wild type and mice were analyzed and compared by Kruskal-Wallis test with pairwise Mann-Whitney U test.
We found the inductive effects of LPS on liver IL-6 mRNA expression to be more pronounced under parenteral iron loading. Upon LPS administration, splenic erythroferrone (ERFE) mRNA levels were reduced only in iron-treated mice, whereas, liver bone morphogenetic protein 6 (BMP6) mRNA levels were decreased under both control and parenteral iron loading conditions. Despite the altered expression of the aforementioned hepcidin regulators, the stimulatory effect of LPS on hepcidin mRNA expression was blunt in iron-treated mice. Contrary to the blunted hepcidin response, LPS treatment suppressed FPN1 mRNA expression in the liver, spleen, and duodenum, as well as reduced serum iron levels of mice with parenteral iron loading.
Our study suggests that a hypoferremic response to LPS-induced acute inflammation is maintained in thalassemic mice with parenteral iron loading in a hepcidin-independent manner.
铁调素通过诱导铁输出蛋白铁转运蛋白1(FPN1)降解,进而降低血清铁水平来调控铁稳态。铁调素表达受多种因素影响,包括铁储备、无效红细胞生成和炎症。然而,在地中海贫血状态下这些因素之间的相互作用仍不清楚。本研究旨在确定在有/无右旋糖酐铁肠外补铁的地中海贫血( )小鼠中,铁稳态对脂多糖(LPS)急性炎症诱导的低铁血症和转录反应。
野生型和 小鼠连续两天每天肌肉注射5mg右旋糖酐铁。平衡2周后,腹腔注射单剂量1μg/g体重的LPS诱导急性炎症。铁负荷和急性炎症的对照组接受等量的盐溶液。在注射LPS(或盐水)后6小时采集血液和组织样本。通过Kruskal-Wallis检验和两两Mann-Whitney U检验分析并比较野生型和 小鼠的铁参数、铁调素mRNA表达以及参与铁转运和代谢的基因。
我们发现肠外补铁时LPS对肝脏IL-6 mRNA表达的诱导作用更明显。给予LPS后,仅在补铁小鼠中脾脏红细胞铁调素(ERFE)mRNA水平降低,而在对照和肠外补铁条件下肝脏骨形态发生蛋白6(BMP6)mRNA水平均降低。尽管上述铁调素调节因子的表达发生了改变,但LPS对补铁的 小鼠铁调素mRNA表达的刺激作用减弱。与铁调素反应减弱相反,LPS处理抑制了肝脏、脾脏和十二指肠中FPN1 mRNA表达,以及降低了肠外补铁的 小鼠的血清铁水平。
我们的研究表明,在有肠外补铁的地中海贫血小鼠中,对LPS诱导的急性炎症的低铁血症反应以铁调素非依赖的方式维持。